Voyager Therapeutics Inc (VYGR)
8.23
+0.13
(+1.60%)
USD |
NASDAQ |
May 24, 16:00
8.23
0.00 (0.00%)
After-Hours: 20:00
Voyager Therapeutics Cash from Operations (TTM): 13.12M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 13.12M |
| December 31, 2023 | 77.92M |
| September 30, 2023 | 89.44M |
| June 30, 2023 | 94.28M |
| March 31, 2023 | 76.63M |
| December 31, 2022 | -12.51M |
| September 30, 2022 | 10.93M |
| June 30, 2022 | 6.427M |
| March 31, 2022 | 2.195M |
| December 31, 2021 | -53.52M |
| September 30, 2021 | -86.70M |
| June 30, 2021 | -90.73M |
| March 31, 2021 | -89.21M |
| December 31, 2020 | -96.72M |
| September 30, 2020 | -98.10M |
| June 30, 2020 | -94.94M |
| March 31, 2020 | -105.29M |
| Date | Value |
|---|---|
| December 31, 2019 | 48.67M |
| September 30, 2019 | 47.68M |
| June 30, 2019 | 51.61M |
| March 31, 2019 | 60.66M |
| December 31, 2018 | -15.89M |
| September 30, 2018 | -6.373M |
| June 30, 2018 | -4.613M |
| March 31, 2018 | 1.554M |
| December 31, 2017 | -61.35M |
| September 30, 2017 | -59.61M |
| June 30, 2017 | -53.91M |
| March 31, 2017 | -47.29M |
| December 31, 2016 | -42.48M |
| September 30, 2016 | -38.95M |
| June 30, 2016 | -35.51M |
| March 31, 2016 | -32.78M |
| December 31, 2015 | 41.30M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-105.29M
Minimum
Mar 2020
94.28M
Maximum
Jun 2023
-10.44M
Average
4.311M
Median
Cash from Operations (TTM) Benchmarks
| Ligand Pharmaceuticals Inc | 34.36M |
| Stereotaxis Inc | -8.683M |
| United Therapeutics Corp | 979.70M |
| MEI Pharma Inc | -43.78M |
| Agios Pharmaceuticals Inc | -300.75M |